Afstyla recombinant and Omadacycline Intravenous
Determining the interaction of Afstyla recombinant and Omadacycline Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Afstyla (recombinant)
Generic Name: omadacycline
Brand name: Nuzyra
Synonyms: Omadacycline (oral/injection), Omadacycline
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Afstyla recombinant-Omadacycline oral/injection
- Afstyla recombinant-Omadacycline Tablets
- Afstyla recombinant-Omadacycline Tosylate
- Afstyla recombinant-Omalizumab
- Afstyla recombinant-Omalizumab Subcutaneous
- Afstyla recombinant-Ombitasvir, Paritaprevir, and Ritonavir
- Omadacycline Intravenous-Aftera
- Omadacycline Intravenous-Aftertest Topical Pain Relief
- Omadacycline Intravenous-Agalsidase beta
- Omadacycline Intravenous-Agalsidase beta Intravenous
- Omadacycline Intravenous-Agenerase
- Omadacycline Intravenous-Aggrastat